Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 1/20 | 0.43 |
| ▸ | GNAO1 | P09471 | 11/20 | 0.40 |
| ▸ | GNAI3 | P08754 | 10/20 | 0.40 |
| ▸ | GNAI1 | P63096 | 10/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | GBA1 | P04062 | 1/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.34 |
| ▸ | HTR2A | P28223 | 1/20 | 0.34 |
| ▸ | HTR2C | P28335 | 1/20 | 0.34 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.34 |
| ▸ | HTR7 | P34969 | 1/20 | 0.34 |
| ▸ | HTR2B | P41595 | 1/20 | 0.34 |
| ▸ | HTR3A | P46098 | 1/20 | 0.34 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.34 |
| ▸ | HTR4 | Q13639 | 1/20 | 0.34 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.34 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4239877 | 0.94 | GNAO1 (0.43) | CHRM1GNAO1GNAI3GNAI1GBA1 | |
| SCHEMBL20487794 | 0.92 | GNAO1 (0.46) | CHRM1GNAO1GNAI3GNAI1GBA1 | |
| SCHEMBL9741247 | 0.92 | GNAO1 (0.46) | CHRM1GNAO1GNAI3GNAI1GBA1 | |
| Hydrochloric Acid SCHEMBL27157910 | 0.92 | GNAO1 (0.46) | CHRM1GNAO1GNAI3GNAI1GBA1 | |
| SCHEMBL2632683 | 0.88 | CHRM1 (0.51) | CHRM1GNAO1GNAI3GNAI1SMN1; SMN2 | |
| SCHEMBL2632445 | 0.88 | CHRM1 (0.51) | CHRM1GNAO1GNAI3GNAI1SMN1; SMN2 | |
| SCHEMBL10049922 | 0.88 | CHRM1 (0.51) | CHRM1GNAO1GNAI3GNAI1SMN1; SMN2 | |
| SCHEMBL2149346 | 0.86 | SLC6A2 (0.36) | CHRM1GNAO1GNAI3GNAI1SLC6A2 | |
| Hydrochloric Acid SCHEMBL1223342 | 0.84 | GNAO1 (0.37) | CHRM1GNAO1GNAI3GNAI1SLC6A2 | |
| SCHEMBL5986706 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240262832-A1 | SMALL MOLECULE MODULATORS OF GLUCOCEREBROSIDASE ACTIVITY AND USES THEREOF | VANQUA BIO, INC. (US) | 2024-08-08 | — | — | US | disclosed |
| WO-2024054602-A1 | HETEROBIFUNCTIONAL COMPOUNDS AND METHODS OF TREATING DISEASE | HALDA THERAPEUTICS OPCO, INC. (US) | 2024-03-14 | — | — | WO | disclosed |
| EP-4329881-A1 | SMALL MOLECULE MODULATORS OF GLUCOCEREBROSIDASE ACTIVITY AND USES THEREOF | Vanqua Bio, Inc. (US) | 2024-03-06 | — | — | EP | disclosed |
| CN-117642404-A | Small molecule modulators of glucocerebrosidase activity and uses thereof | 凡况生化公司 | 2024-03-01 | — | — | CN | disclosed |
| WO-2022232383-A1 | SMALL MOLECULE MODULATORS OF GLUCOCEREBROSIDASE ACTIVITY AND USES THEREOF | VANQUA BIO, INC. (US) | 2022-11-03 | — | — | WO | disclosed |
| WO-2022220725-A1 | LPXH INHIBITORS AS ANTI-INFECTIVE AGENTS | ZAMARATSKI EDOUARD (SE) | 2022-10-20 | — | — | WO | disclosed |
| US-8722681-B2 | N-sulfonyl thiazolylpiperazine derivatives and related N-sulfonyl heterocyclic derivatives for the treatment of neuro degenerative diseases | NV REMYND (BE) | 2014-05-13 | — | — | US | disclosed |
| US-20100197703-A1 | N-SULFONYL THIAZOLYLPIPERAZINE DERIVATIVES AND RELATED N-SULFONYL HETEROCYCLIC DERIVATIVES FOR THE TREATMENT OF NEURO DEGENERATIVE DISEASES | NV REMYND (BE) | 2010-08-05 | — | — | US | disclosed |
| US-7645754-B2 | Pyrrolopyrimidine A2B selective antagonist compounds, their synthesis and use | OSI PHARMACEUTICALS, INC. (US) | 2010-01-12 | — | — | US | disclosed |
| WO-2009125870-A1 | PYRIMIDINE, PYRIDINE AND TRIAZINE DERIVATIVES AS MAXI-K CHANNEL OPENERS. | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2009-10-15 | — | — | WO | disclosed |
| EP-1042290-A1 | AROMATIC SULFONE HYDROXAMIC ACID METALLOPROTEASE INHIBITOR | G.D. SEARLE & CO. (US) | 2000-10-11 | — | — | EP | disclosed |
| WO-2000050396-A1 | AROMATIC SULFONE HYDROXAMIC ACID METALLOPROTEASE INHIBITOR | G.D. SEARLE & CO. (US) | 2000-08-31 | — | — | WO | disclosed |
| WO-1999025687-A1 | AROMATIC SULFONE HYDROXAMIC ACID METALLOPROTEASE INHIBITOR | G.D. SEARLE & CO. (US) | 1999-05-27 | — | — | WO | disclosed |
| EP-0804252-A2 | MONOAMINE, DIAMIDE, THIOL-CONTAINING METAL CHELATING AGENTS | DIATECH, INC. (US) | 1997-11-05 | — | — | EP | disclosed |
| CN-1158090-A | Metal chelating agent containing monoamine, hydrazine and thiol | DIATECH INC (US) | 1997-08-27 | — | — | CN | disclosed |
| EP-0772459-A1 | TECHNETIUM-99m LABELED IMAGING AGENTS | DIATECH, INC. (US) | 1997-05-14 | — | — | EP | disclosed |
| WO-1995033497-A1 | MONOAMINE, DIAMIDE, THIOL-CONTAINING METAL CHELATING AGENTS | DIATECH, INC. (US) | 1995-12-14 | — | — | WO | disclosed |
| WO-1995029708-A1 | TECHNETIUM-99m LABELED IMAGING AGENTS | DIATECH, INC. (US) | 1995-11-09 | — | — | WO | disclosed |
| EP-0225886-A1 | NEW PYRIDAZINE COMPOSITIONS, PRODUCTION PROCESS THEREOF AND FUNGICIDES AND ALGICIDES CONTAINING THEM. | CHEMIE LINZ AG (AT) | 1987-06-24 | — | — | EP | disclosed |
| WO-1986006719-A1 | NEW PYRIDAZINE COMPOSITIONS, PRODUCTION PROCESS THEREOF AND FUNGICIDES AND ALGICIDES CONTAINING THEM | CHEMIE LINZ AKTIENGESELLSCHAFT (AT) | 1986-11-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100197703-A1 | N-SULFONYL THIAZOLYLPIPERAZINE DERIVATIVES AND RELATED N-SULFONYL HETEROCYCLIC DERIVATIVES FOR THE TREATMENT OF NEURO DEGENERATIVE DISEASES | SMN1; SMN2, HTT, SNCA | CHRM1 4237/4885GNAO1 2751/4885GNAI3 2570/4885 |
| US-20240262832-A1 | SMALL MOLECULE MODULATORS OF GLUCOCEREBROSIDASE ACTIVITY AND USES THEREOF | GBA1, GAA, GBA2 | CHRM1 4128/4885GNAO1 66/4885GNAI3 119/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.